Cargando…

Correction to: Inhibition of microRNA-451 is associated with increased expression of Macrophage Migration Inhibitory Factor and mitigation of the cardio-pulmonary phenotype in a murine model of Bronchopulmonary Dysplasia

Detalles Bibliográficos
Autores principales:	Gilfillan, Margaret, Das, Pragnya, Shah, Dilip, Alam, Mohammad Afaque, Bhandari, Vineet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245040/ https://www.ncbi.nlm.nih.gov/pubmed/32446299 http://dx.doi.org/10.1186/s12931-020-01378-0

Ejemplares similares

Inhibition of microRNA-451 is associated with increased expression of Macrophage Migration Inhibitory Factor and mitgation of the cardio-pulmonary phenotype in a murine model of Bronchopulmonary Dysplasia
por: Gilfillan, Margaret, et al.
Publicado: (2020)

NOVEL BIOMARKERS OF BRONCHOPULMONARY DYSPLASIA AND BRONCHOPULMONARY DYSPLASIA-ASSOCIATED PULMONARY HYPERTENSION
por: Sahni, Mitali, et al.
Publicado: (2020)

miR34a: a master regulator in the pathogenesis of bronchopulmonary dysplasia
por: Das, Pragnya, et al.
Publicado: (2018)

Pulmonary Biomarkers of Bronchopulmonary Dysplasia
por: Thompson, Alecia, et al.
Publicado: (2008)

Small molecular modulation of macrophage migration inhibitory factor in the hyperoxia-induced mouse model of bronchopulmonary dysplasia
por: Sun, Huanxing, et al.
Publicado: (2013)

Patho-mechanisms of the origins of bronchopulmonary dysplasia
por: Sahni, Mitali, et al.
Publicado: (2021)

Recent advances in understanding and management of bronchopulmonary dysplasia
por: Sahni, Mitali, et al.
Publicado: (2020)

Can biomarkers be used to predict bronchopulmonary dysplasia?()
por: Bhandari, Vineet, et al.
Publicado: (2020)

Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6
por: Chaubey, Sushma, et al.
Publicado: (2018)

Genomics, microbiomics, proteomics, and metabolomics in bronchopulmonary dysplasia
por: Lal, Charitharth Vivek, et al.
Publicado: (2018)

Understanding the Impact of Infection, Inflammation, and Their Persistence in the Pathogenesis of Bronchopulmonary Dysplasia
por: Balany, Jherna, et al.
Publicado: (2015)

Drug Therapy Trials for the Prevention of Bronchopulmonary Dysplasia: Current and Future Targets
por: Bhandari, Vineet
Publicado: (2014)

Chitin-Derived AVR-48 Prevents Experimental Bronchopulmonary Dysplasia (BPD) and BPD-Associated Pulmonary Hypertension in Newborn Mice
por: Das, Pragnya, et al.
Publicado: (2021)

Non-Invasive Ventilatory Strategies to Decrease Bronchopulmonary Dysplasia—Where Are We in 2021?
por: Dumpa, Vikramaditya, et al.
Publicado: (2021)

How to decrease bronchopulmonary dysplasia in your neonatal intensive care unit today and “tomorrow”
por: Nelin, Leif D., et al.
Publicado: (2017)

S-Nitrosoglutathione Attenuates Airway Hyperresponsiveness in Murine Bronchopulmonary Dysplasia
por: Raffay, Thomas M., et al.
Publicado: (2016)

Cerebral Myelination in a Bronchopulmonary Dysplasia Murine Model
por: Chen, Wenwen, et al.
Publicado: (2023)

Factors associated with development of early and late pulmonary hypertension in preterm infants with bronchopulmonary dysplasia
por: Sheth, Sudip, et al.
Publicado: (2019)

Phenotypes of Bronchopulmonary Dysplasia
por: Wang, Shih-Hsin, et al.
Publicado: (2020)

Small Immunomodulatory Molecules as Potential Therapeutics in Experimental Murine Models of Acute Lung Injury (ALI)/Acute Respiratory Distress Syndrome (ARDS)
por: Shah, Dilip, et al.
Publicado: (2021)

Need for Supplemental Oxygen at Discharge in Infants with Bronchopulmonary Dysplasia Is Not Associated with Worse Neurodevelopmental Outcomes at 3 Years Corrected Age
por: Lodha, Abhay, et al.
Publicado: (2014)

Incidence of Bronchopulmonary Dysplasia in Korea
por: Choi, Chang Won, et al.
Publicado: (2012)

Oxidative Stress and Bronchopulmonary Dysplasia
por: Perrone, Serafina, et al.
Publicado: (2012)

Present and Future of Bronchopulmonary Dysplasia
por: Bonadies, Luca, et al.
Publicado: (2020)

Perspectives on Probiotics and Bronchopulmonary Dysplasia
por: Yang, Kun, et al.
Publicado: (2020)

Pulmonary hypertension in bronchopulmonary dysplasia
por: Hansmann, Georg, et al.
Publicado: (2020)

Bronchopulmonary Dysplasia: Pathogenesis and Pathophysiology
por: Dankhara, Nilesh, et al.
Publicado: (2023)

Efficacy of Sildenafil in Infants with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension
por: Dillon, Kacie, et al.
Publicado: (2023)

MiR-451 suppresses the growth, migration, and invasion of prostate cancer cells by targeting macrophage migration inhibitory factor
por: Wang, Gang, et al.
Publicado: (2019)

Pulmonary hypertension in infants with bronchopulmonary dysplasia
por: Kim, Gi Beom
Publicado: (2010)

Pulmonary Hemosiderosis in Children with Bronchopulmonary Dysplasia
por: Kurahara, David, et al.
Publicado: (2014)

Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
por: Rivera, Lidys, et al.
Publicado: (2016)

Hospital management of severe bronchopulmonary dysplasia
por: Moretti, Corrado, et al.
Publicado: (2015)

Correlation of Retinopathy of Prematurity with Bronchopulmonary Dysplasia
por: Podraza, Wojciech, et al.
Publicado: (2018)

The rate and pattern of bronchopulmonary dysplasia in Kuwait
por: Al-Essa, Mazen, et al.
Publicado: (2004)

Impact of bronchopulmonary dysplasia on brain and retina
por: Poon, Annie Wing Hoi, et al.
Publicado: (2016)

Strategies to improve outcomes of bronchopulmonary dysplasia
por: Jung, Young Hwa, et al.
Publicado: (2019)

New Pharmacologic Approaches to Bronchopulmonary Dysplasia
por: Roberts, Katelyn, et al.
Publicado: (2021)

An Update on the Prevention and Management of Bronchopulmonary Dysplasia
por: Hennelly, Marissa, et al.
Publicado: (2021)

Pharmacotherapy in Bronchopulmonary Dysplasia: What Is the Evidence?
por: Sakaria, Rishika P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3o17kabocbv5b55uha8f15cvm2